414 Genomic profiling using a clinical next generation sequencing (NGS) assay reveals genomic alterations to guide targeted therapy in advanced neuroblastoma patients
| Autor: | Ali, S., Sanford, E.M., Hawryluk, M.J., Chmielecki, J., Wang, K., Palmer, G.A., Palma, N.A., Morosini, D., Erlich, R., Yelensky, R., Lipson, D., Ross, J.S., Mosse, Y., Stephens, P.J., Maris, J.M., Miller, V.A. |
|---|---|
| Zdroj: | In European Journal of Cancer November 2014 50 Supplement 6:132-132 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect